✦ LIBER ✦

A067 Thalidomide/Dexamethasone (THALDEX) as Salvage Therapy for Multiple Myeloma Patients First Relapsing

✍ Scribed by Charlinski, G; Jedrzejczak, WW; Wiater, EM; Dwilewicz-Trojaczek, J

Book ID: 118629220
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 91 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70447-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thalidomide–dexamethasone as primary the

Thalidomide–dexamethasone as primary therapy for advanced multiple myeloma

✍ Michael Wang; Donna M. Weber; Kay Delasalle; Raymond Alexanian 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views

## Abstract The value of thalidomide–dexamethasone was assessed in 26 consecutive, previously untreated patients with multiple myeloma of high tumor mass. All showed Hgb < 8.5 g/dL, serum calcium > 11.5 mg/dL, or both. The response rate was 73%, frequency of early death < 3 months was 5%, projected

Thalidomide, dexamethasone and lovastati

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

✍ Marek Hus; Norbert Grzasko; Marta Szostek; Andrzej Pluta; Grzegorz Helbig; Dariu 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 218 KB

Long-term results of thalidomide and dex

Long-term results of thalidomide and dexamethasone (thal–dex) as therapy of first relapse in multiple myeloma

✍ Elena Zamagni; Alessandro Petrucci; Patrizia Tosi; Paola Tacchetti; Giulia Perro 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 257 KB

Thalidomide plus dexamethasone is an eff

Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant

✍ Antonio Palumbo; Patrizia Falco; Maria Teresa Ambrosini; Maria Teresa Petrucci; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Bortezomib, doxorubicin, and dexamethaso

Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety

✍ Sung Sook Lee; Cheolwon Suh; Bong-Seog Kim; Jooseop Chung; Young-Don Joo; Hun-Mo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 151 KB

Bortezomib, thalidomide, and dexamethaso

Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma : A retrospective study

✍ Jonathan L. Kaufman; Ajay Nooka; Mark Vrana; Charise Gleason; L. Thompson Heffne 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract ## BACKGROUND: This single‐center retrospective study determined the efficacy of bortezomib, thalidomide, and dexamethasone (BTD) as induction for patients with multiple myeloma (MM) who were eligible for autologous stem cell transplantation (ASCT). ## METHODS: Patients with symptoma